India's Healthcare Research Shifts Focus to Prevention and Precision Medicine
Union Minister Dr. Jitendra Singh emphasizes a transformative approach in healthcare research aimed at prevention and tailored treatments.
India is prioritizing preventive healthcare and precision medicine to tackle rising lifestyle diseases.
Over 10,000 genomes have been sequenced to understand genetic diversity and health risks.
The government is expanding access to treatment for rare genetic diseases and enhancing public health initiatives.
In a significant shift in healthcare strategy, Union Minister of State for Science and Technology, Dr. Jitendra Singh, announced on Sunday that India is increasingly focusing on preventive measures and precision medicine. Speaking at THE WEEK Health Summit 2026 in New Delhi, he highlighted the urgent need to address lifestyle-related diseases, particularly among younger populations, as conditions like diabetes and obesity become more prevalent.
Dr. Singh pointed out that the traditional methods of treating diseases are evolving towards more scientific and precise interventions. He attributed the rise in health issues among youth to changing dietary habits and reduced physical activity, stressing that a proactive approach is essential. The Minister emphasized that public awareness and community involvement are crucial in combating these health challenges, rather than relying solely on healthcare professionals.
The Minister also underscored the advancements in biotechnology and genetic research that are paving the way for innovative treatment strategies. He revealed that genome sequencing of 10,000 individuals from 84 different populations has been conducted to gain insights into India’s genetic diversity and associated health risks. This research has identified over 400 genetic traits, which could inform future healthcare strategies.
In addition to genomic research, Dr. Singh discussed the government's initiatives, such as the HPV vaccination program that has successfully immunized over 5 million adolescent girls against cervical cancer. He noted the development of an indigenous DNA vaccine during the COVID-19 pandemic as a landmark achievement in India's vaccine research capabilities. Furthermore, he mentioned ongoing studies into biomarkers for gestational diabetes, which aim to identify women at risk of developing Type 2 diabetes.
Looking ahead, Dr. Singh called for enhanced collaboration among government bodies, research institutions, and private sector partners to translate scientific advancements into practical healthcare solutions. He warned young people about the dangers of health misinformation and the unregulated use of medications, urging them to seek guidance from qualified professionals and rely on credible scientific data.




